Disease/Infection News

RSS

Vaxzevria vaccine boosts mucosal immunity in COVID-19 recovered

Study highlights the ability of the Vaxzevria vaccine in inducing robust mucosal antibody responses, especially in COVID-19-recovered individuals, showcasing a notable defense against various SARS-CoV-2 variants. However, it emphasizes the need for booster doses to enhance anti-SARS-CoV-2 mucosal immunity, especially in infection-naïve individuals, to broaden protection against emerging viral variants.

28 Sep 2023

Plastic waste in the oceans may spread antibiotic resistance

Bacteria discharged to the oceans in sewage and wastewater thrive on the biofilms that form on plastic waste. This may be leading to the somewhat unanticipated problem of antimicrobial resistance.

28 Sep 2023

Weighing the risks and benefits of COVID-19 precautions in 2023

A new editorial paper was published in Oncotarget's Volume 14 on September 22, 2023, entitled, "Reassessing the risks and benefits of COVID-19 precautions in 2023."

28 Sep 2023

Social isolation linked to higher depression levels during the COVID-19 pandemic

Higher levels of depressive symptoms have been reported during the COVID-19 pandemic compared with other times in history, and as much as three times higher than prior to the pandemic.

28 Sep 2023

SARS-CoV-2 virus can trigger dangerous immune response in artery-clogging plaques

In some patients, infection with the pandemic virus SARS-CoV-2 can trigger a dangerous immune response in hardened fatty deposits (plaques) lining the heart's largest blood vessels, a new study shows.

28 Sep 2023

Commonly used anti-viral drugs reduce risk of hospitalization, death in patients with mild COVID-19

New Cleveland Clinic-led research shows commonly used COVID-19 anti-viral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduce risk of hospitalization and death in high-risk patients with mild disease, even with Omicron subvariants.

28 Sep 2023

Hospitalized COVID patients displayed multiple organ abnormalities five months after infection

A study looking at the longer-term impact of COVID-19 has found that nearly a third of patients displayed abnormalities in multiple organs five months after infection, some of which have been shown through previous work to be evidence of tissue damage.

28 Sep 2023

SARS-CoV-2 infects coronary vessels, inducing plaque inflammation

SARS-CoV-2, the virus that causes COVID-19, can directly infect the arteries of the heart and cause the fatty plaque inside arteries to become highly inflamed, increasing the risk of heart attack and stroke, according to a study funded by the National Institutes of Health.

28 Sep 2023

Natural antibiotic thiostrepton reveals new hope for inflammatory bowel disease treatment

Researchers explored the therapeutic impact of Thiostrepton on experimental colitis by examining its effects on colon inflammation and determining its targets through various biochemical approaches.

28 Sep 2023

Fatty liver disease susceptibility: study identifies interaction between estrogen receptor and genetic variant in women

Researchers pursued evidence of whether the interaction between the patatin-like phospholipase domain-containing 3 p.I148M variant and the female sex at the genetic and molecular level explains why premenopausal women remain protected against fatty liver disease, while a rapidly progressive disease ensues in some peri- and postmenopausal women.

28 Sep 2023

Examining the cardiac pathology in fatal cases of yellow fever

The characteristics of yellow fever (YF)-related myocardial damage.

28 Sep 2023

Non-alcoholic fatty liver disease linked to higher risk of blood clots in healthy adults

Recent study in Scientific Reports finds a link between nonalcoholic fatty liver disease (NAFLD) and a higher risk of venous thromboembolism (VTE) among healthy Korean adults. The research suggests that NAFLD may contribute to a hypercoagulable state, increasing the risk of VTE.

27 Sep 2023

Yeast in the gut linked to Crohn's disease inflammation, opening new doors for treatment

New study in Nature Medicine links yeast cells in the gastrointestinal tract to abnormal immune responses causing inflammation in Crohn's disease patients. The research suggests that these yeast-reactive T-cells could be a potential therapeutic target, offering new avenues for treatment.

27 Sep 2023

Researchers develop new way to boost immune cells' ability to fight TB

Tuberculosis is old-;ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, but it hasn't been cured yet.

27 Sep 2023

Hawk Data Pro: A vital "One Health" surveillance tool for rabies control

Scientists have revealed that the use of an animal rescue system – Hawk Data Pro – proved to be a vital "One Health" surveillance tool as part of a rapid response to a potentially deadly rabies outbreak in Pune city, India.

27 Sep 2023

Mutations on a key SARS-CoV-2 viral protein linked to extreme immune responses

Mutations on a key SARS-CoV-2 viral protein are linked to extreme immune responses and could offer a novel vaccine target.

27 Sep 2023

New technology could pave the way to rapid infection testing

New technology could pave the way to a future of rapid testing in hospitals and at home for both covid and urinary tract infection.

27 Sep 2023

As covid infections rise, nursing homes are still waiting for vaccines

"Covid is not pretty in a nursing home," said Deb Wityk, a 70-year-old retired massage therapist who lives in one called Spurgeon Manor, in rural Iowa. She twice contracted the disease and is eager to get the newly approved vaccine because she has chronic lymphocytic leukemia, which weakens her immune system.

27 Sep 2023

Surrey researchers develop new rapid electronic diagnostic test for infectious diseases

A new molecular test for bacteria and viruses, including SARS-CoV-2 has been developed by scientists at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.

27 Sep 2023

Zoonotic spillover safeguarding: computationally designed antigen targets range of coronaviruses

Researchers used an interdisciplinary approach incorporating phylogenetics, 3D protein modeling, and plasmid design to identify and computationally design an antigen representing the core of most currently known sarbecoviruses.

27 Sep 2023

Disease/Infection News

Vaxzevria vaccine boosts mucosal immunity in COVID-19 recovered

Plastic waste in the oceans may spread antibiotic resistance

Weighing the risks and benefits of COVID-19 precautions in 2023

Social isolation linked to higher depression levels during the COVID-19 pandemic

SARS-CoV-2 virus can trigger dangerous immune response in artery-clogging plaques

Commonly used anti-viral drugs reduce risk of hospitalization, death in patients with mild COVID-19

Hospitalized COVID patients displayed multiple organ abnormalities five months after infection

SARS-CoV-2 infects coronary vessels, inducing plaque inflammation

Natural antibiotic thiostrepton reveals new hope for inflammatory bowel disease treatment

Fatty liver disease susceptibility: study identifies interaction between estrogen receptor and genetic variant in women

Examining the cardiac pathology in fatal cases of yellow fever

Non-alcoholic fatty liver disease linked to higher risk of blood clots in healthy adults

Yeast in the gut linked to Crohn's disease inflammation, opening new doors for treatment

Researchers develop new way to boost immune cells' ability to fight TB

Hawk Data Pro: A vital "One Health" surveillance tool for rabies control

Mutations on a key SARS-CoV-2 viral protein linked to extreme immune responses

New technology could pave the way to rapid infection testing

As covid infections rise, nursing homes are still waiting for vaccines

Surrey researchers develop new rapid electronic diagnostic test for infectious diseases

Zoonotic spillover safeguarding: computationally designed antigen targets range of coronaviruses

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News